CY2341B1 - Bicyclic amino acids. - Google Patents
Bicyclic amino acids.Info
- Publication number
- CY2341B1 CY2341B1 CY0300028A CY0300028A CY2341B1 CY 2341 B1 CY2341 B1 CY 2341B1 CY 0300028 A CY0300028 A CY 0300028A CY 0300028 A CY0300028 A CY 0300028A CY 2341 B1 CY2341 B1 CY 2341B1
- Authority
- CY
- Cyprus
- Prior art keywords
- amino acids
- bicyclic amino
- bicyclic
- acids
- amino
- Prior art date
Links
- -1 Bicyclic amino acids Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19705450A DE19705450A1 (en) | 1997-02-13 | 1997-02-13 | Bicyclic aromatic amino acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY2341B1 true CY2341B1 (en) | 2004-02-06 |
Family
ID=7820093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY0300028A CY2341B1 (en) | 1997-02-13 | 2003-03-17 | Bicyclic amino acids. |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0964856B1 (en) |
| JP (1) | JP4327257B2 (en) |
| KR (1) | KR20000071030A (en) |
| CN (1) | CN1085205C (en) |
| AR (1) | AR010894A1 (en) |
| AT (1) | ATE225776T1 (en) |
| AU (1) | AU735313B2 (en) |
| BR (1) | BR9807345A (en) |
| CA (1) | CA2280727C (en) |
| CY (1) | CY2341B1 (en) |
| CZ (1) | CZ297366B6 (en) |
| DE (2) | DE19705450A1 (en) |
| DK (1) | DK0964856T3 (en) |
| ES (1) | ES2183332T3 (en) |
| HU (1) | HUP0001138A3 (en) |
| ID (1) | ID22533A (en) |
| NO (1) | NO313289B1 (en) |
| PL (1) | PL335101A1 (en) |
| PT (1) | PT964856E (en) |
| RU (1) | RU2187506C2 (en) |
| SI (1) | SI0964856T1 (en) |
| SK (1) | SK284646B6 (en) |
| TR (1) | TR199901962T2 (en) |
| WO (1) | WO1998035949A1 (en) |
| ZA (1) | ZA981178B (en) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040063790A1 (en) * | 1996-05-31 | 2004-04-01 | The Scripps Research Institute | Methods for inhibition of angiogenesis |
| CA2327673C (en) | 1998-04-09 | 2009-08-25 | Meiji Seika Kaisha, Ltd. | Aminopiperidine derivatives as integrin .alpha.v.beta.3 antagonists |
| JP3936844B2 (en) | 1999-04-13 | 2007-06-27 | ビーエーエスエフ アクチェンゲゼルシャフト | Integrin receptor ligand |
| WO2001010844A1 (en) | 1999-08-05 | 2001-02-15 | Meiji Seika Kaisha, Ltd. | φ-AMINO-α-HYDROXYCARBOXYLIC ACID DERIVATIVES HAVING INTEGRIN αvβ3 ANTAGONISM |
| EP1244616A1 (en) * | 1999-12-24 | 2002-10-02 | SmithKline Beecham plc | (hetero)bicyclylmethanesulfonylamino-substituted hydroxamic acid derivatives |
| US6617461B2 (en) * | 2000-01-25 | 2003-09-09 | Kaneka Corporation | Process for preparation of optically active N-substituted azetidine-2-carboxylic acids |
| DK1381382T3 (en) * | 2000-11-01 | 2009-02-02 | Merck Patent Gmbh | Methods and Preparations for the Treatment of Eye Diseases |
| CN100571772C (en) * | 2000-11-01 | 2009-12-23 | 默克专利有限公司 | Use of antagonists of the integrin receptors α v β 3 and/or α v β 5 for the production of medicaments for the treatment of eye diseases |
| US7025987B2 (en) | 2001-05-30 | 2006-04-11 | The Scripps Research Institute | Delivery system for nucleic acids |
| ES2243744T3 (en) * | 2001-08-01 | 2005-12-01 | Merck Patent Gmbh | INTEGRIN INHIBITORS FOR THE TREATMENT OF EYE DISEASES. |
| EP1474162A1 (en) * | 2002-02-14 | 2004-11-10 | MERCK PATENT GmbH | Methods and compositions for the treatment of eye diseases |
| FR2847254B1 (en) * | 2002-11-19 | 2005-01-28 | Aventis Pharma Sa | NOVEL VITRONECTIN RECEPTOR ANTAGONIST DERIVATIVES, PROCESS FOR PREPARING THEM, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS REFLECTING THEM |
| DE10305784A1 (en) * | 2003-02-12 | 2004-08-26 | Merck Patent Gmbh | 3-Oxo-3,4-dihydro-2H-benz-(1,4)-oxazin-6-yl)-propionic acid derivative preparation, for use as integrin inhibitors with e.g. antitumor action, by multi-stage process giving diastereomerically pure product |
| DE10337863A1 (en) | 2003-08-18 | 2005-03-17 | Merck Patent Gmbh | Use of chromene-4-one derivatives |
| EP2484365B1 (en) * | 2004-06-04 | 2013-10-02 | The Scripps Research Institute | Compositions and method for treatment of neovascular diseases |
| UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| SI2380881T1 (en) * | 2008-12-26 | 2017-05-31 | Sumitomo Dainippon Pharma Co., Ltd. | Novel bicyclic heterocyclic compound |
| WO2011024987A1 (en) * | 2009-08-31 | 2011-03-03 | 塩野義製薬株式会社 | Aromatic fused heterocyclic derivative and pharmaceutical composition containing same |
| JP6080226B2 (en) | 2012-03-06 | 2017-02-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Benzodioxane for inhibiting leukotriene production in combination with other active substances |
| WO2014014874A1 (en) | 2012-07-17 | 2014-01-23 | Boehringer Ingelheim International Gmbh | Pyrazole derivatives which inhibit leukotriene production |
| US9573957B2 (en) | 2013-07-15 | 2017-02-21 | Boehringer Ingelheim International Gmbh | Inhibitors of leukotriene production |
| JP6353899B2 (en) | 2013-07-15 | 2018-07-04 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Inhibitors of leukotriene production |
| MX2016015467A (en) | 2014-05-30 | 2017-03-23 | Pfizer | Carbonitrile derivatives as selective androgen receptor modulators. |
| WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
| JP2024542963A (en) | 2021-11-01 | 2024-11-19 | アルカヘスト,インコーポレイテッド | Benzodioxane Modulators of Leukotriene A4 Hydrolase (LTA4H) for the Prevention and Treatment of Age-Related Diseases - Patent application |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3151690A1 (en) * | 1981-12-29 | 1983-07-07 | Hoechst Ag, 6230 Frankfurt | Novel derivatives of bicyclic amino acids, process for their preparation, compositions containing them and their use, and also novel bicyclic amino acids as intermediates and process for their preparation |
| FR2674854B1 (en) * | 1991-04-04 | 1995-03-03 | Bouchara | NEW QUINOLONES THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS THEREOF. |
| AU675689B2 (en) * | 1992-12-01 | 1997-02-13 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| JPH10501222A (en) * | 1994-05-27 | 1998-02-03 | メルク エンド カンパニー インコーポレーテッド | Compounds for inhibiting osteoclast-mediated bone resorption |
| DE19548709A1 (en) * | 1995-12-23 | 1997-07-03 | Merck Patent Gmbh | Tyrosine derivatives |
| SK176898A3 (en) * | 1996-06-28 | 1999-05-07 | Merck Patent Gmbh | Phenylalamine derivatives as integrin inhibitors |
| DE19654483A1 (en) * | 1996-06-28 | 1998-01-02 | Merck Patent Gmbh | Phenylalanine derivatives |
-
1997
- 1997-02-13 DE DE19705450A patent/DE19705450A1/en not_active Withdrawn
-
1998
- 1998-02-06 DK DK98908063T patent/DK0964856T3/en active
- 1998-02-06 CZ CZ0287599A patent/CZ297366B6/en not_active IP Right Cessation
- 1998-02-06 CA CA002280727A patent/CA2280727C/en not_active Expired - Fee Related
- 1998-02-06 AU AU66206/98A patent/AU735313B2/en not_active Ceased
- 1998-02-06 EP EP98908063A patent/EP0964856B1/en not_active Expired - Lifetime
- 1998-02-06 BR BR9807345A patent/BR9807345A/en not_active Application Discontinuation
- 1998-02-06 SI SI9830304T patent/SI0964856T1/en unknown
- 1998-02-06 CN CN98803959A patent/CN1085205C/en not_active Expired - Fee Related
- 1998-02-06 PL PL98335101A patent/PL335101A1/en unknown
- 1998-02-06 WO PCT/EP1998/000636 patent/WO1998035949A1/en not_active Ceased
- 1998-02-06 ES ES98908063T patent/ES2183332T3/en not_active Expired - Lifetime
- 1998-02-06 SK SK1071-99A patent/SK284646B6/en unknown
- 1998-02-06 AT AT98908063T patent/ATE225776T1/en not_active IP Right Cessation
- 1998-02-06 RU RU99119223/04A patent/RU2187506C2/en not_active IP Right Cessation
- 1998-02-06 ID IDW990812A patent/ID22533A/en unknown
- 1998-02-06 PT PT98908063T patent/PT964856E/en unknown
- 1998-02-06 JP JP53530398A patent/JP4327257B2/en not_active Expired - Fee Related
- 1998-02-06 KR KR1019997007297A patent/KR20000071030A/en not_active Ceased
- 1998-02-06 DE DE59805895T patent/DE59805895D1/en not_active Expired - Lifetime
- 1998-02-06 TR TR1999/01962T patent/TR199901962T2/en unknown
- 1998-02-06 HU HU0001138A patent/HUP0001138A3/en unknown
- 1998-02-12 ZA ZA981178A patent/ZA981178B/en unknown
- 1998-02-13 AR ARP980100654A patent/AR010894A1/en not_active Application Discontinuation
-
1999
- 1999-08-12 NO NO19993901A patent/NO313289B1/en not_active IP Right Cessation
-
2003
- 2003-03-17 CY CY0300028A patent/CY2341B1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2341B1 (en) | Bicyclic amino acids. | |
| DE69810130D1 (en) | Rotationspumpe mit tauchrotor | |
| GB9718609D0 (en) | Fusion protein | |
| HU9801045D0 (en) | Substituted diamino-carboxylic acids | |
| DE19881579D2 (en) | Kompressor mit überlastenkopplungseinrichtung | |
| GB9703681D0 (en) | Protein complemention | |
| GB9719879D0 (en) | Protein | |
| GB9718110D0 (en) | Peptides | |
| ZA965538B (en) | Somatostatin peptides. | |
| GB9700154D0 (en) | Peptides | |
| GB9715064D0 (en) | Protein expression | |
| ZA984322B (en) | Sucrose-binding proteins | |
| AU1999999A (en) | Contryphan peptides | |
| GB9720784D0 (en) | Protein | |
| GB9704559D0 (en) | Protease | |
| GB9703103D0 (en) | Protein | |
| GB9719670D0 (en) | Protein | |
| GB9720785D0 (en) | Protein | |
| GB9701024D0 (en) | Peptides | |
| GB9713146D0 (en) | Peptides | |
| GB9706556D0 (en) | Peptides | |
| GB9703850D0 (en) | Novel protein | |
| GB9714075D0 (en) | Novel protein | |
| GB9703827D0 (en) | Novel protein | |
| GB9706119D0 (en) | Novel protein |